http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-301013-B6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 1999-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f54bd477c2128d201c62e7b8fa04921f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e95e35072f0e5daf87ecb179883dafb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21dc61ab6f7f8c2c4ba09a67deb61acf
publicationDate 2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CZ-301013-B6
titleOfInvention Medicament for the sedation of a critically ill patient
abstract The use of dexmedetomidine or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for sedating a critically ill patient receiving intensive care while the patient remains awake and oriented. Preferably, dexmedetomidine or a pharmaceutically acceptable salt thereof is substantially the only active agent or exclusively the only active agent.
priorityDate 1998-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0331374-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0413487-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0424059-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6321225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449170443
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462508

Total number of triples: 55.